Imvax Secures $29 Million to Advance Glioblastoma Therapy Trial
PHILADELPHIA, PA — Imvax, Inc, recently closed a $29 million financing round from existing investors. This marks the latest milestone in the company’s fundraising efforts, which have totaled $86 million …
Imvax Secures $29 Million to Advance Glioblastoma Therapy Trial Read More